Facing crackdown in Canada, drug makers offered billions in price cuts

6 February 2019 - Delayed rules would change countries Canada compares its prices to, dropping U.S. ...

Read more →

Ottawa’s push for lower drug costs may hurt patients, stunt innovation

24 January 2019 - The federal government’s plan to lower prescription drug prices could impede access and thus limit the ...

Read more →

Trudeau spreads the big Pharmacare myth that scores of Canadians can’t afford medicine

23 January 2019 - Across every income group, people pay more for media entertainment than prescription medicine. ...

Read more →

The strange world of Canadian drug pricing

22 January 2019 - Imagine yourself in some hip new coffee shop. All you want is your standard cup to ...

Read more →

Canada’s drug pricing regulator brings rare allegation of excessive pricing against Horizon Pharma

17 January 2019 - Canada’s drug-pricing regulator is accusing an Irish pharmaceutical company of charging an excessive price for a ...

Read more →

Lowering the price of new drugs comes with too high a cost — Canadians' health

14 November 2018 - Ottawa wants to apply new price regulations, which will only cut manufacturer profits and deter the introduction ...

Read more →

B.C. to sue opioid makers for health care expenses of overdose crisis

29 August 2018 - The British Columbia Government will sue opioid manufacturers including Purdue Pharma in an effort to recoup ...

Read more →

Ottawa’s drug-pricing changes threaten Canadians who suffer from rare diseases

28 August 2018 - The federal government’s plan to increasingly regulate the costs of pharmaceuticals could mean Canadians with cystic ...

Read more →

Debunking the myths about a Canadian pharmacare program

24 July 2018 - A national pharmacare program may one day be a reality in Canada. Myths abound about how it ...

Read more →

Proposed PMPRB changes could limit Canada’s access to new drugs

20 July 2018 - While the federal government’s proposed amendments to Canada’s patented medicines regulations are aimed at reducing the ...

Read more →

Drug patents could be Canada's special weapon in U.S. trade dispute

16 June 2018 - Taking an 'asymmetrical' approach and targeting U.S. intellectual property has worked in the past, experts say. ...

Read more →

Where do the Ontario political parties stand on prescription drug coverage?

5 June 2018 - Medication access may help to decide an election for the first time in Canada — it ...

Read more →

Universal pharmacare the right prescription for Canada

19 April 2018 - A Commons committee is supporting the full funding of a national drug plan, a sign that the ...

Read more →

Innovative drugs need a new regulatory approach

10 April 2018 - Innovative drugs help people enjoy longer, healthier, more productive lives. They also allow our health-care systems ...

Read more →

Gene therapy: international regulatory and health technology assessment activities and reimbursement status

28 March 2018 - There is widespread variation in the definition of gene therapy used by international regulatory bodies and a ...

Read more →